Company / Current Liabilities per Share
Jazz Pharmaceuticals Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$36.99
FY2025
5-year range
$14.41 / $36.99
FY2021-FY2025
Trend
+121.7%
vs FY2024
Sector context
#6 of 210
Health Care
What the data says
Among 210 Health Care companies, Jazz Pharmaceuticals is in the bottom 3% for current liabilities per share. Increased from $24.31 to $36.99 over the past 2 years.
Based on SEC 10-K filings.
36.99 in FY2025 with a 5-year CAGR of +26.0%. Top quartile in the Health Care sector.
Increased from $24.31 to $36.99 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +34.7%
- 5-Year CAGR
- +26.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 210This company $36.99 Sector average $15.78
▼
+134.4% above sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 121.7% year-over-year.
- Ranks #6 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $36.99 | +121.7% |
| FY2024 | $16.68 | -31.4% |
| FY2023 | $24.31 | +60.6% |
| FY2022 | $15.14 | +5.1% |
| FY2021 | $14.41 | +23.7% |
| FY2020 | $11.64 | +84.4% |
| FY2019 | $6.32 | +7.7% |
| FY2018 | $5.87 | +19.4% |
| FY2017 | $4.91 | +17.0% |
| FY2016 | $4.20 | +12.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026